Remdesivir Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04501978Therapeutics for Inpatients With COVID-19
NCT04252664Mild/Moderate 2019-nCoV Remdesivir RCT
NCT04492475Adaptive COVID-19 Treatment Trial 3 (ACTT-3)